HTG Receives US Patent for HTG EdgeSeq Chemistry Coupling Quantitative Nuclease Protection With Next-Generation-SequencingContinue reading→

PHOENIX (June 16, 2014) – The Arizona Commerce Authority (ACA) today announced 10 finalists in the Spring 2014 Arizona Innovation Challenge (AIC), its bi-annual business plan competition awarding $3 million annually to talented entrepreneurs.Continue reading→

Transplant For Life (TFL) becomes Arizona’s only FDA registered and accredited independent transplant tissue bank.  Located in Phoenix, TFL is dedicated to enhancing lives in the community by facilitating the gift of transplant tissue donation.Continue reading→

AZBio Member Senestech has entered into an exclusive licensing agreement with Neogen to manufacture and market a rodent control product that uses fertility control to manage rat populations.Continue reading→

An interdisciplinary team of UA researchers has received a $2.098 million grant to study recovery of language in the early phase of recovery after a stroke.Continue reading→

TGen Concussion Research Fund is first under ACF’s new Jerry Colangelo Center for Sports PhilanthropyContinue reading→

TUCSON, AZ– – Today HTG Molecular Diagnostics announced the availability of HTG EdgeSeq miRNA Whole Transcriptome Assay for measuring the expression of 2,275 human microRNAs (miRNAs) described in the miRBase v20 database.Continue reading→

VisionGate Inc., an in vitro diagnostics company that has developed the patented Cell-CT^®,a 3D cell imaging platform being utilized in early disease detection, recently added three new esteemed business leaders to its Board of Directors. The directors come on board at a pivotal time for VisionGate, as its revolutionary, non-invasive test for the early detection of lung cancer – LuCED^® – is poised to enter the market.Continue reading→